Role of Nods in bacterial infection

Microbes and Infection

Volumn 9, Issue 5, 2007, Pages 629-636

  Bourhis, Lionel Le ^a   Werts, Catherine ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Leucine rich repeats; Muropeptides; Nods; Pattern recognition receptors; Peptidoglycan; Toll like receptors

Indexed keywords

BACTERIAL PROTEIN; CARBOHYDRATE BINDING PROTEIN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PATTERN RECOGNITION RECEPTOR; PEPTIDOGLYCAN; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; BACTERIAL INFECTION; CELL MATURATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; INFECTION SENSITIVITY; INNATE IMMUNITY; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MOTIF; SHIGELLA FLEXNERI; SHORT SURVEY; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BACTERIAL INFECTIONS; HUMANS; INFLAMMATION; NOD1 SIGNALING ADAPTOR PROTEIN; NOD2 SIGNALING ADAPTOR PROTEIN; RECEPTORS, CELL SURFACE;

BACTERIA (MICROORGANISMS);

EID: 34247177912     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2007.01.014     Document Type: Short Survey

References (69)

1. Lemaitre B., Nicolas E., Michaut L., Reichhart J.M., and Hoffmann J.A. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86 (1996) 973-983
2. Mariathasan S., Newton K., Monack D.M., Vucic D., French D.M., Lee W.P., Roose-Girma M., Erickson S., and Dixit V.M. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430 (2004) 213-218
3. Mariathasan S., Weiss D.S., Dixit V.M., and Monack D.M. Innate immunity against Francisella tularensis is dependent on the ASC/caspase-1 axis. J. Exp. Med. 202 (2005) 1043-1049
4. Werts C., Girardin S.E., and Philpott D.J. TIR, CARD and PYRIN: three domains for an antimicrobial triad. Cell Death Differ 13 (2006) 798-815
5. Girardin S.E., Boneca I.G., Viala J., Chamaillard M., Labigne A., Thomas G., Philpott D.J., and Sansonetti P.J. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278 (2003) 8869-8872
6. Inohara N., Ogura Y., Fontalba A., Gutierrez O., Pons F., Crespo J., Fukase K., Inamura S., Kusumoto S., Hashimoto M., Foster S.J., Moran A.P., Fernandez-Luna J.L., and Nunez G. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J. Biol. Chem. 278 (2003) 5509-5512
7. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cezard J.P., Belaiche J., Almer S., Tysk C., O'Morain C.A., Gassull M., Binder V., Finkel Y., Cortot A., Modigliani R., Laurent-Puig P., Gower-Rousseau C., Macry J., Colombel J.F., Sahbatou M., and Thomas G. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411 (2001) 599-603
8. Kanazawa N., Okafuji I., Kambe N., Nishikomori R., Nakata-Hizume M., Nagai S., Fuji A., Yuasa T., Manki A., Sakurai Y., Nakajima M., Kobayashi H., Fujiwara I., Tsutsumi H., Utani A., Nishigori C., Heike T., Nakahata T., and Miyachi Y. Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome. Blood 105 (2005) 1195-1197
9. Miceli-Richard C., Lesage S., Rybojad M., Prieur A.M., Manouvrier-Hanu S., Hafner R., Chamaillard M., Zouali H., Thomas G., and Hugot J.P. CARD15 mutations in Blau syndrome. Nat. Genet. 29 (2001) 19-20
10. Chamaillard M., Hashimoto M., Horie Y., Masumoto J., Qiu S., Saab L., Ogura Y., Kawasaki A., Fukase K., Kusumoto S., Valvano M.A., Foster S.J., Mak T.W., Nunez G., and Inohara N. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat. Immunol. 4 (2003) 702-707
11. Girardin S.E., Boneca I.G., Carneiro L.A., Antignac A., Jehanno M., Viala J., Tedin K., Taha M.K., Labigne A., Zahringer U., Coyle A.J., DiStefano P.S., Bertin J., Sansonetti P.J., and Philpott D.J. Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 300 (2003) 1584-1587
12. Hysi P., Kabesch M., Moffatt M.F., Schedel M., Carr D., Zhang Y., Boardman B., von Mutius E., Weiland S.K., Leupold W., Fritzsch C., Klopp N., Musk A.W., James A., Nunez G., Inohara N., and Cookson W.O. NOD1 variation, immunoglobulin E and asthma. Hum. Mol. Genet. 14 (2005) 935-941
13. Weidinger S., Klopp N., Rummler L., Wagenpfeil S., Novak N., Baurecht H.J., Groer W., Darsow U., Heinrich J., Gauger A., Schafer T., Jakob T., Behrendt H., Wichmann H.E., Ring J., and Illig T. Association of NOD1 polymorphisms with atopic eczema and related phenotypes. J. Allergy Clin. Immunol. 116 (2005) 177-184
14. Boneca I.G. The role of peptidoglycan in pathogenesis. Curr. Opin. Microbiol. 8 (2005) 46-53
15. Girardin S.E., Travassos L.H., Herve M., Blanot D., Boneca I.G., Philpott D.J., Sansonetti P.J., and Mengin-Lecreulx D. Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J. Biol. Chem. 278 (2003) 41702-41708
16. Travassos L.H., Girardin S.E., Philpott D.J., Blanot D., Nahori M.A., Werts C., and Boneca I.G. Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Rep. 5 (2004) 1000-1006
17. Chamaillard M., Philpott D., Girardin S.E., Zouali H., Lesage S., Chareyre F., Bui T.H., Giovannini M., Zaehringer U., Penard-Lacronique V., Sansonetti P.J., Hugot J.P., and Thomas G. Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc. Natl. Acad. Sci. USA. 100 (2003) 3455-3460
18. Chedid L. Muramyl peptides as possible endogenous immunopharmacological mediators. Microbiol. Immunol. 27 (1983) 723-732
19. Magalhaes J.G., Philpott D.J., Nahori M.A., Jehanno M., Fritz J., Bourhis L.L., Viala J., Hugot J.P., Giovannini M., Bertin J., Lepoivre M., Mengin-Lecreulx D., Sansonetti P.J., and Girardin S.E. Murine Nod1 but not its human orthologue mediates innate immune detection of tracheal cytotoxin. EMBO Rep. 6 12 (2005) 120-127
20. Goldman W.E., and Herwaldt L.A. Bordetella pertussis tracheal cytotoxin. Dev. Biol. Stand. 61 (1985) 103-111
21. Goldman W.E., and Cookson B.T. Structure and functions of the Bordetella tracheal cytotoxin. Tokai J. Exp. Clin. Med. 13 Suppl. (1988) 187-191
22. Girardin S.E., Jehanno M., Mengin-Lecreulx D., Sansonetti P.J., Alzari P.M., and Philpott D.J. Identification of the critical residues involved in peptidoglycan detection by nod1. J. Biol. Chem. 280 (2005) 38648-38656
23. Tanabe T., Chamaillard M., Ogura Y., Zhu L., Qiu S., Masumoto J., Ghosh P., Moran A., Predergast M.M., Tromp G., Williams C.J., Inohara N., and Nunez G. Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition. Embo J. 23 (2004) 1587-1597
24. Li J., Moran T., Swanson E., Julian C., Harris J., Bonen D.K., Hedl M., Nicolae D.L., Abraham C., and Cho J.H. Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations. Hum. Mol. Genet. 13 (2004) 1715-1725
25. Netea M.G., Ferwerda G., de Jong D.J., Girardin S.E., Kullberg B.J., and van der Meer J.W. NOD2 3020insC mutation and the pathogenesis of Crohn's disease: impaired IL-1beta production points to a loss-of-function phenotype. Neth. J. Med. 63 (2005) 305-308
26. Girardin S.E., Tournebize R., Mavris M., Page A.L., Li X., Stark G.R., Bertin J., DiStefano P.S., Yaniv M., Sansonetti P.J., and Philpott D.J. CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. EMBO Rep. 2 (2001) 736-742
27. Philpott D.J., Yamaoka S., Israel A., and Sansonetti P.J. Invasive Shigella flexneri activates NF-kappa B through a lipopolysaccharide-dependent innate intracellular response and leads to IL-8 expression in epithelial cells. J. Immunol. 165 (2000) 903-914
28. Fritz J.H., Girardin S.E., Fitting C., Werts C., Mengin-Lecreulx D., Caroff M., Cavaillon J.M., Philpott D.J., and Adib-Conquy M. Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists. Eur. J. Immunol. 35 (2005) 2459-2470
29. Netea M.G., Ferwerda G., de Jong D.J., Werts C., Boneca I.G., Jehanno M., Van Der Meer J.W., Mengin-Lecreulx D., Sansonetti P.J., Philpott D.J., Dharancy S., and Girardin S.E. The frameshift mutation in Nod2 results in unresponsiveness not only to Nod2- but also Nod1-activating peptidoglycan agonists. J. Biol. Chem. 280 (2005) 35859-35867
30. Inohara N., Koseki T., Lin J., del Peso L., Lucas P.C., Chen F.F., Ogura Y., and Nunez G. An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways. J. Biol. Chem. 275 (2000) 27823-27831
31. Kobayashi K., Inohara N., Hernandez L.D., Galan J.E., Nunez G., Janeway C.A., Medzhitov R., and Flavell R.A. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 416 (2002) 194-199
32. Ogura Y., Inohara N., Benito A., Chen F.F., Yamaoka S., and Nunez G. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J. Biol. Chem. 276 (2001) 4812-4818
33. Abbott D.W., Wilkins A., Asara J.M., and Cantley L.C. The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO. Curr. Biol. 14 (2004) 2217-2227
34. Inohara N., Koseki T., del Peso L., Hu Y., Yee C., Chen S., Carrio R., Merino J., Liu D., Ni J., and Nunez G. Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB. J. Biol. Chem. 274 (1999) 14560-14567
35. Martinon F., Burns K., and Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell. 10 (2002) 417-426
36. Yoo N.J., Park W.S., Kim S.Y., Reed J.C., Son S.G., Lee J.Y., and Lee S.H. Nod1, a CARD protein, enhances pro-interleukin-1beta processing through the interaction with pro-caspase-1. Biochem. Biophys. Res. Commun. 299 (2002) 652-658
37. Martinon F., Agostini L., Meylan E., and Tschopp J. Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome. Curr. Biol. 14 (2004) 1929-1934
38. Li L., Bin L.H., Li F., Liu Y., Chen D., Zhai Z., and Shu H.B. TRIP6 is a RIP2-associated common signaling component of multiple NF-kappaB activation pathways. J. Cell Sci. 118 (2005) 555-563
39. Barnich N., Hisamatsu T., Aguirre J.E., Xavier R., Reinecker H.C., and Podolsky D.K. GRIM-19 interacts with nucleotide oligomerization domain 2 and serves as downstream effector of anti-bacterial function in intestinal epithelial cells. J. Biol. Chem. 280 (2005) 19021-19026
40. Chen C.M., Gong Y., Zhang M., and Chen J.J. Reciprocal cross-talk between Nod2 and TAK1 signaling pathways. J. Biol. Chem. 279 (2004) 25876-25882
41. Kufer T.A., Kremmer E., Banks D.J., and Philpott D.J. Role for erbin in bacterial activation of Nod2. Infect. Immun. 74 (2006) 3115-3124
42. McDonald C., Chen F.F., Ollendorff V., Ogura Y., Marchetto S., Lecine P., Borg J.P., and Nunez G. A role for erbin in the regulation of NOD2-dependent NF-kappa B signaling. J. Biol. Chem. 280 48 (2005) 40301-40309
43. Bausinger H., Lipsker D., Ziylan U., Manie S., Briand J.P., Cazenave J.P., Muller S., Haeuw J.F., Ravanat C., de la Salle H., and Hanau D. Endotoxin-free heat-shock protein 70 fails to induce APC activation. Eur. J. Immunol. 32 (2002) 3708-3713
44. Hirschfeld M., Ma Y., Weis J.H., Vogel S.N., and Weis J.J. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J. Immunol. 165 (2000) 618-622
45. Traub S., Kubasch N., Morath S., Kresse M., Hartung T., Schmidt R.R., and Hermann C. Structural requirements of synthetic muropeptides to synergize with lipopolysaccharide in cytokine induction. J. Biol. Chem. 279 (2004) 8694-8700
46. Tada H., Aiba S., Shibata K., Ohteki T., and Takada H. Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells. Infect. Immun. 73 (2005) 7967-7976
47. van Heel D.A., Ghosh S., Butler M., Hunt K., Foxwell B.M., Mengin-Lecreulx D., and Playford R.J. Synergistic enhancement of Toll-like receptor responses by NOD1 activation. Eur. J. Immunol. 35 (2005) 2471-2476
48. Netea M.G., Ferwerda G., de Jong D.J., Jansen T., Jacobs L., Kramer M., Naber T.H., Drenth J.P., Girardin S.E., Kullberg B.J., Adema G.J., and Van der Meer J.W. Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release. J. Immunol. 174 (2005) 6518-6523
49. van Heel D.A., Ghosh S., Hunt K.A., Mathew C.G., Forbes A., Jewell D.P., and Playford R.J. Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease. Gut 54 (2005) 1553-1557
50. Uehara A., Yang S., Fujimoto Y., Fukase K., Kusumoto S., Shibata K., Sugawara S., and Takada H. Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture. Cell Microbiol. 7 (2005) 53-61
51. Netea M.G., Kullberg B.J., de Jong D.J., Franke B., Sprong T., Naber T.H., Drenth J.P., and Van der Meer J.W. NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease. Eur. J. Immunol. 34 (2004) 2052-2059
52. Netea M.G., Azam T., Ferwerda G., Girardin S.E., Walsh M., Park J.S., Abraham E., Kim J.M., Yoon D.Y., Dinarello C.A., and Kim S.H. IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1{beta} and IL-6 production through a caspase 1-dependent mechanism. Proc. Natl. Acad. Sci. USA. 102 45 (2005) 16309-16314
53. Abreu M.T., Vora P., Faure E., Thomas L.S., Arnold E.T., and Arditi M. Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J. Immunol. 167 (2001) 1609-1616
54. Kim J.G., Lee S.J., and Kagnoff M.F. Nod1 is an essential signal transducer in intestinal epithelial cells infected with bacteria that avoid recognition by toll-like receptors. Infect. Immun. 72 (2004) 1487-1495
55. Opitz B., Forster S., Hocke A.C., Maass M., Schmeck B., Hippenstiel S., Suttorp N., and Krull M. Nod1-mediated endothelial cell activation by Chlamydophila pneumoniae. Circ. Res. 96 (2005) 319-326
56. Travassos L.H., Carneiro L.A., Girardin S.E., Boneca I.G., Lemos R., Bozza M.T., Domingues R.C., Coyle A.J., Bertin J., Philpott D.J., and Plotkowski M.C. Nod1 participates in the innate immune response to Pseudomonas aeruginosa. J Biol Chem. 280 44 (2005) 36714-36718
57. Ferwerda G., Girardin S.E., Kullberg B.-J., de Jong D., Lagenberg D.M.L., van Crevel R., Adema G.J., Ottenhoff T.H.M., van der Meer J.W.M., and Netea M.G. Nod2 and TLR2 are two non-redundant recognition systems of mycobacterium tuberculosis. PLoS Pathogens 1 (2005) 280-285
58. Worsaae N., Staehr Johansen K., and Christensen K.C. Impaired in vitro function of neutrophils in Crohn's disease. Scand. J. Gastroenterol. 17 (1982) 91-96
59. Hisamatsu T., Suzuki M., Reinecker H.C., Nadeau W.J., McCormick B.A., and Podolsky D.K. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 124 (2003) 993-1000
60. Viala J., Chaput C., Boneca I.G., Cardona A., Girardin S.E., Moran A.P., Athman R., Memet S., Huerre M.R., Coyle A.J., DiStefano P.S., Sansonetti P.J., Labigne A., Bertin J., Philpott D.J., and Ferrero R.L. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat. Immunol. 5 (2004) 1166-1174
61. Wada A., Ogushi K., Kimura T., Hojo H., Mori N., Suzuki S., Kumatori A., Se M., Nakahara Y., Nakamura M., Moss J., and Hirayama T. Helicobacter pylori-mediated transcriptional regulation of the human beta-defensin 2 gene requires NF-kappaB. Cell Microbiol. 3 (2001) 115-123
62. Kobayashi K.S., Chamaillard M., Ogura Y., Henegariu O., Inohara N., Nunez G., and Flavell R.A. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307 (2005) 731-734
63. Ogura Y., Lala S., Xin W., Smith E., Dowds T.A., Chen F.F., Zimmermann E., Tretiakova M., Cho J.H., Hart J., Greenson J.K., Keshav S., and Nunez G. Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis. Gut 52 (2003) 1591-1597
64. Voss E., Wehkamp J., Wehkamp K., Stange E.F., Schroder J.M., and Harder J. NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2. J. Biol. Chem. 281 4 (2006) 2005-2011
65. Wehkamp J., Harder J., Weichenthal M., Schwab M., Schaffeler E., Schlee M., Herrlinger K.R., Stallmach A., Noack F., Fritz P., Schroder J.M., Bevins C.L., Fellermann K., and Stange E.F. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut. 53 (2004) 1658-1664
66. Wehkamp J., Salzman N.H., Porter E., Nuding S., Weichenthal M., Petras R.E., Shen B., Schaeffeler E., Schwab M., Linzmeier R., Feathers R.W., Chu H., Lima Jr. H., Fellermann K., Ganz T., Stange E.F., and Bevins C.L. Reduced Paneth cell {alpha}-defensins in ileal Crohn's disease. Proc. Natl. Acad. Sci. USA. (2005)
67. Fortier A., Diez E., and Gros P. Naip5/Birc1e and susceptibility to Legionella pneumophila. Trends Microbiol. 13 (2005) 328-335
68. Quintela J.C., de Pedro M.A., Zollner P., Allmaier G., and Garcia-del Portillo F. Peptidoglycan structure of Salmonella typhimurium growing within cultured mammalian cells. Mol. Microbiol. 23 (1997) 693-704
69. Rebeil R., Ernst R.K., Gowen B.B., Miller S.I., and Hinnebusch B.J. Variation in lipid A structure in the pathogenic yersiniae. Mol. Microbiol. 52 (2004) 1363-1373